Oruka Therapeutics, Inc. Property, Plant and Equipment, Gross
Oruka Therapeutics, Inc. (ORKA) had Property, Plant and Equipment, Gross of $222.00 thousand as of 2024-06-30, per its 10-Q filed 2024-08-01.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2024-08-01
- 2024-06-30: Property, Plant and Equipment, Gross $222.00K.
- 2024-03-31: Property, Plant and Equipment, Gross $222.00K.
- 2023-12-31: Property, Plant and Equipment, Gross $222.00K.
- 2023-09-30: Property, Plant and Equipment, Gross $229.00K.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2024-06-30 | $222.00K 10-Q · filed 2024-08-01 |
| 2024-03-31 | $222.00K 10-Q · filed 2024-04-25 |
| 2023-12-31 | $222.00K 10-Q · filed 2024-08-01 |
| 2023-09-30 | $229.00K 10-Q · filed 2023-10-18 |
| 2023-06-30 | $229.00K 10-Q · filed 2023-07-21 |
| 2023-03-31 | $229.00K 10-Q · filed 2023-04-24 |
| 2022-12-31 | $229.00K 10-K · filed 2024-02-01 |
| 2022-09-30 | $231.00K 10-Q · filed 2022-10-28 |
| 2022-06-30 | $241.00K 10-Q · filed 2022-08-02 |
| 2022-03-31 | $241.00K 10-Q · filed 2022-05-02 |
| 2021-12-31 | $243.00K 10-K · filed 2023-02-24 |
| 2021-09-30 | $265.00K 10-Q · filed 2021-11-02 |
| 2021-06-30 | $257.00K 10-Q · filed 2021-08-04 |
| 2021-03-31 | $280.00K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $271.00K 10-K · filed 2022-03-14 |
| 2020-09-30 | $270.00K 10-Q · filed 2020-11-02 |
| 2020-06-30 | $356.00K 10-Q · filed 2020-08-05 |
| 2020-03-31 | $380.00K 10-Q · filed 2020-05-06 |
| 2019-12-31 | $377.00K 10-K · filed 2021-03-18 |
| 2019-09-30 | $391.00K 10-Q · filed 2019-11-06 |
| 2019-06-30 | $389.00K 10-Q · filed 2019-08-01 |
| 2019-03-31 | $398.00K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $398.00K 10-K · filed 2020-02-18 |
| 2018-09-30 | $432.00K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $431.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $444.00K 10-Q · filed 2018-05-08 |
| 2017-12-31 | $443.00K 10-K · filed 2019-02-27 |
| 2017-09-30 | $451.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $450.00K 10-Q · filed 2017-08-03 |
| 2017-03-31 | $453.00K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $453.00K 10-K · filed 2018-03-22 |
| 2016-09-30 | $449.00K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $448.00K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $405.00K 10-Q · filed 2016-05-11 |
| 2015-12-31 | $415.00K 10-K · filed 2017-03-21 |
| 2015-09-30 | $415.00K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $425.00K 10-Q · filed 2015-08-11 |
| 2015-03-31 | $420.00K 10-Q · filed 2015-05-12 |
| 2014-12-31 | $418.00K 10-K · filed 2016-03-17 |
| 2014-09-30 | $404.00K 10-Q · filed 2014-11-12 |
| 2014-06-30 | $429.00K 10-Q · filed 2014-08-13 |
| 2014-03-31 | $514.00K 10-Q · filed 2014-05-13 |
| 2013-12-31 | $514.00K 10-K · filed 2015-03-19 |
| 2013-09-30 | $509.00K 10-Q · filed 2013-11-13 |
| 2013-06-30 | $517.00K 10-Q · filed 2013-08-13 |
| 2013-03-31 | $508.00K 10-Q · filed 2013-05-13 |
| 2012-12-31 | $533.00K 10-K · filed 2014-03-20 |
| 2012-09-30 | $534.00K 10-Q · filed 2012-11-13 |
| 2012-06-30 | $534.00K 10-Q · filed 2012-08-13 |
| 2011-12-31 | $533.00K 10-K · filed 2013-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |